Kyobo 8 Special Purpose Acquisition Company (307280) - Net Assets
Based on the latest financial reports, Kyobo 8 Special Purpose Acquisition Company (307280) has net assets worth ₩41.96 Billion KRW (≈ $28.44 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩49.65 Billion ≈ $33.65 Million USD) and total liabilities (₩7.69 Billion ≈ $5.21 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Kyobo 8 Special Purpose Acquisition Comp assets under control for the complete picture of this company's asset base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩41.96 Billion |
| % of Total Assets | 84.51% |
| Annual Growth Rate | 16.69% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 3.45 |
Kyobo 8 Special Purpose Acquisition Company - Net Assets Trend (2022–2025)
This chart illustrates how Kyobo 8 Special Purpose Acquisition Company's net assets have evolved over time, based on quarterly financial data. Check Kyobo 8 Special Purpose Acquisition Comp (307280) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Net Assets for Kyobo 8 Special Purpose Acquisition Company (2022–2025)
The table below shows the annual net assets of Kyobo 8 Special Purpose Acquisition Company from 2022 to 2025. For live valuation and market cap data, see 307280 market cap.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | ₩42.62 Billion ≈ $28.89 Million |
+14.37% |
| 2024-12-31 | ₩37.27 Billion ≈ $25.26 Million |
+14.23% |
| 2023-12-31 | ₩32.62 Billion ≈ $22.11 Million |
+21.62% |
| 2022-12-31 | ₩26.83 Billion ≈ $18.18 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Kyobo 8 Special Purpose Acquisition Company's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 65.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ₩32.94 Billion | 77.09% |
| Other Components | ₩9.79 Billion | 22.91% |
| Total Equity | ₩42.73 Billion | 100.00% |
Kyobo 8 Special Purpose Acquisition Company Competitors by Market Cap
The table below lists competitors of Kyobo 8 Special Purpose Acquisition Company ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Econframe Bhd
KLSE:0227
|
$25.05 Million |
|
Perdana Gapura Prima Tbk
JK:GPRA
|
$25.06 Million |
|
Eupe Corporation Bhd
KLSE:6815
|
$25.06 Million |
|
Renta Corporacion Real Estate SA
MC:REN
|
$25.07 Million |
|
A2Z Infra Engineering Limited
NSE:A2ZINFRA
|
$25.05 Million |
|
Reservoir Link Energy Bhd
KLSE:0219
|
$25.04 Million |
|
Environmental Group Ltd (the)
AU:EGL
|
$25.04 Million |
|
THE INX DIGITAL CO.INC.
F:FN4
|
$25.03 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Kyobo 8 Special Purpose Acquisition Company's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 37,206,873,560 to 42,726,088,470, a change of 5,519,214,910 (14.8%).
- Net income of 6,615,249,000 contributed positively to equity growth.
- Dividend payments of 709,193,400 reduced retained earnings.
- Share repurchases of 383,051,250 reduced equity.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩6.62 Billion | +15.48% |
| Dividends Paid | ₩709.19 Million | -1.66% |
| Share Repurchases | ₩383.05 Million | -0.9% |
| Other Changes | ₩-3.79 Million | -0.01% |
| Total Change | ₩- | 14.83% |
Book Value vs Market Value Analysis
This analysis compares Kyobo 8 Special Purpose Acquisition Company's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.90x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.41x to 0.90x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-12-31 | ₩3841.64 | ₩5420.00 | x |
| 2023-12-31 | ₩4541.80 | ₩5420.00 | x |
| 2024-12-31 | ₩5244.41 | ₩5420.00 | x |
| 2025-12-31 | ₩6023.48 | ₩5420.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Kyobo 8 Special Purpose Acquisition Company utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 15.48%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.77%
- • Asset Turnover: 0.74x
- • Equity Multiplier: 1.11x
- Recent ROE (15.48%) is above the historical average (14.94%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 11.93% | 11.99% | 0.69x | 1.45x | ₩519.38 Million |
| 2023 | 17.06% | 18.56% | 0.69x | 1.33x | ₩2.28 Billion |
| 2024 | 15.29% | 18.69% | 0.74x | 1.11x | ₩1.97 Billion |
| 2025 | 15.48% | 18.77% | 0.74x | 1.11x | ₩2.34 Billion |
Industry Comparison
This section compares Kyobo 8 Special Purpose Acquisition Company's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $566,238,380,700
- Average return on equity (ROE) among peers: 2.46%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Kyobo 8 Special Purpose Acquisition Company (307280) | ₩41.96 Billion | 11.93% | 0.18x | $25.05 Million |
| DIO Corporation (039840) | $160.36 Billion | 6.95% | 1.00x | $113.42 Million |
| Cellumed Co. Ltd (049180) | $37.28 Billion | -19.07% | 0.74x | $37.57 Million |
| Interojo Inc (119610) | $189.15 Billion | 12.79% | 0.39x | $118.30 Million |
| SD Biosensor Inc (137310) | $2.83 Trillion | -16.52% | 0.34x | $511.52 Million |
| Dentium (145720) | $162.46 Billion | 18.51% | 0.91x | $239.32 Million |
| M.I.TECH Co.Ltd (179290) | $16.63 Billion | 12.09% | 0.23x | $95.19 Million |
About Kyobo 8 Special Purpose Acquisition Company
Wonbiogen Co., Ltd. manufactures and sells wound dressings in South Korea, rest of Asia, Europe, and internationally. It operates through Wound Dressing and Daily Necessities divisions. The company offers polyurethane foam and hydrocolloid dressings; cosmetics; other dressings; and daily necessities. It also provides medical, organic, and inorganic materials; and laundry detergents. Wonbiogen Co.… Read more